Research Article
Comparison of Diagnostic Yield and Safety between Semirigid Pleuroscopic Cryobiopsy and Forceps Biopsy for Undiagnosed Pleural Effusion
Table 2
Final diagnoses and complications.
| | Cryobiopsy, | Forceps biopsy, | value |
| Sample pieces | 7 (3.5–8) | 6 (5–7.5) | 0.686 | Tissue size | | | | Length (mm) | 9.1 ± 5.7 | 5.3 ± 3.8 | 0.020 | Area (mm2) | 56.0 ± 61.3 | 10.2 ± 14.3 | 0.001 | Volume (mm3) | 232.1 ± 411.4 | 13.4 ± 22.6 | 0.009 | Bleeding | | | | Moderate/severe | 0 | 0 | — | Mild | 3 | 1 | 0.581 | No bleeding | 25 | 16 | 0.581 | Subcutaneous emphysema | 0 | 0 | | Pneumothorax | 0 | 0 | | Pneumomediastinum | 0 | 0 | | Wound infection | 0 | 0 | | Diagnostic rate | 89.3% (25/28) | 88.2% (15/17) | 0.913 | Hospital stay after pleuroscopic biopsy (days), median (IQR) | 11 (8–14.5) | 11 (7–18) | 0.916 | Final diagnosis | | | | Malignancy | 16 (57.1%) | 9 (52.9%) | | Tuberculosis pleurisy | 4 (14.3%) | 3 (17.6%) | | Fibrinous pleuritis | 5 (17.9%) | 2 (11.8%) | | Wegener’s granulomatosis | 0 (0%) | 1 (5.9%) | | Undiagnosed | 3 (10.7%) | 2 (11.8%) | |
|
|